Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Pathologic Complete Response × Radiotherapy, Intensity-Modulated × Clear all

Sponsor

Conditions

Squamous Cell Carcinoma of Head and Neck 29 Head and Neck Neoplasms 23 Prostatic Neoplasms 14 Oropharyngeal Neoplasms 10 Carcinoma, Non-Small-Cell Lung 8 Uterine Cervical Neoplasms 7 Gliosarcoma 7 Glioblastoma 7 Brain Neoplasms 7 Rectal Neoplasms 6 Carcinoma, Squamous Cell 6 Lung Neoplasms 5 Tongue Neoplasms 4 Papillomavirus Infections 4 Pancreatic Neoplasms 4 Neoplasm Metastasis 4 Mouth Neoplasms 4 Laryngeal Neoplasms 4 Astrocytoma 4 Sarcoma 3 Glioma 3 Carcinoma 3 Urinary Bladder Neoplasms 2 Rhabdomyosarcoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Precancerous Conditions 2 Neuroblastoma 2 Neoplasms 2 Mesothelioma, Malignant 2 Leukemia 2

Interventions

temsirolimus 1 sargramostim 1 ruxolitinib 1 rucaparib 1 pazopanib 1 olaparib 1 eltrombopag 1 cc-486 1 Surveys and Questionnaires 1 Nivolumab 1 Monatide (IMS 3015) 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Doxorubicin 1 Docetaxel 1 Diphenhydramine 1 Cytarabine 1 Cyclophosphamide 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡